AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
Onyx Pharmaceuticals Inc (ONXX)
Market is closed
News
- First
- << Previous
- 71 - 80
- Next >>
Onyx Pharmaceuticals, Inc. (ONXX), Cyberonics, Inc. (CYBX) Among Elite Investor's Top Five Positions
To say that William Leland Edwards of Palo Alto Investors invest heavily in healthcare stocks would be, well, a bit of an understatement. The fund’s positions read like a pharmaceutical sales rep’...
Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Is Celgene Corporation (CELG)'s Pipeline a Fit for Your Portfolio?
Few big biotech firms have been as successful recently as Celgene Corporation (NASDAQ:CELG).
Amarin Corporation plc (ADR) (AMRN), Antares Pharma Inc (ATRS): 3 FDA Decisions You Need to Watch in 2013
Sequester or no sequester, the folks at the Food and Drug Administration look to be quite busy in 2013.
Hedge Funds Are Selling Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) was in 24 hedge funds' portfolio at the end of December.
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players - Roche Holding Ltd. (ADR) (RHHBY), AstraZeneca plc (ADR) (AZN), ImmunoGen, Inc. (IMGN)
As I noted two weeks ago, cancer statistics are both staggering and disappointing.
It's Time for AstraZeneca plc (ADR) (AZN) to Save Its Future
The hits keep coming at AstraZeneca plc (ADR) (NYSE:AZN).
5 Can't-Miss Health-Care Events This Week: Zogenix, Inc. (ZGNX), Ariad Pharmaceuticals, Inc. (ARIA)
Normally we have a nice blend of health-care events to take notice of each week.
More Upside on this Biotechnology Giant: Celgene Corporation (CELG)
The Food and Drug Administration added Celgene Corporation (NASDAQ:CELG)’s Pomalyst to the list of approved drugs last Friday.
Pomalyst Takes the Stage: Celgene Corporation (CELG), Johnson & Johnson (JNJ), Onyx Pharmaceuticals, Inc. (ONXX)
What is "it"? The answer is Pomalyst -- Celgene Corporation (NASDAQ:CELG)'s most recently approved drug.
- First
- << Previous
- 71 - 80
- Next >>
Billionaire Hedge Funds
